CompletedNot Applicable

Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting

South Korea3,056 participantsStarted 2008-04

Plain-language summary

The objective of this study is to evaluate the safety and long-term effectiveness of coronary stenting with the everolimus-eluting stent (EES) and to determine clinical device and procedural success during commercial use of EES in the real world. The investigators will compare EES (Xience/Promus, prospective arm) with sirolimus-eluting stent (SES, Cypher, retrospective arm).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient agrees to participate in this study by signing the informed consent form. * Alternatively, a legally authorized patient representative may agree to the patient's participation in this study and sign the informed consent form. Exclusion Criteria: * There are no exclusion criteria for this registry.

What they're measuring

Major Adverse Cardiac Events (composite of cardiac death, non-fatal MI, target lesion revascularization)

Timeframe: 12 months

Trial details

NCT IDNCT00960648

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-01

View on ClinicalTrials.gov More Coronary Artery Disease trials